These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 7776936

  • 1. [Therapy of tuberculosis in the adult].
    Schrappe M, Wassermann K, Kroegel C.
    Med Klin (Munich); 1995 Apr 15; 90(4):229-30. PubMed ID: 7776936
    [No Abstract] [Full Text] [Related]

  • 2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M, Bek E.
    Pneumonol Pol; 1980 Jul 15; 48(7):469-79. PubMed ID: 7433146
    [No Abstract] [Full Text] [Related]

  • 3. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan 15; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

  • 4. [Antitubercular chemotherapy].
    Jouveshomme S, Dautzenberg B.
    Rev Mal Respir; 1997 Dec 15; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [Abstract] [Full Text] [Related]

  • 5. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan 15; 55(1):7-13. PubMed ID: 6988627
    [No Abstract] [Full Text] [Related]

  • 6. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug 04; 37(954):67-70. PubMed ID: 7616907
    [No Abstract] [Full Text] [Related]

  • 7. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
    Dixit R, Sharma S, Nawal CL.
    J Assoc Physicians India; 2008 May 04; 56():390-1. PubMed ID: 18700651
    [No Abstract] [Full Text] [Related]

  • 8. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV.
    Probl Tuberk; 1978 Oct 04; (10):23-8. PubMed ID: 714901
    [No Abstract] [Full Text] [Related]

  • 9. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ, Kwon OJ, Park YK, Lew WJ, Bai GH.
    Eur Respir J; 2005 Sep 04; 26(3):557. PubMed ID: 16135740
    [No Abstract] [Full Text] [Related]

  • 10. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 04; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 11. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A, Hedhiri H, Marzouki M, Jerray M, Djenayah F.
    Bull Int Union Tuberc; 1985 Dec 04; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract] [Full Text] [Related]

  • 12. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T, Rehman F, Mitchison DA, Sarma GR, Reetha AM, Prabhaker R, Tuberculosis Research Centre, Indian Council of Medical Research.
    Trop Med Int Health; 2004 May 04; 9(5):551-8. PubMed ID: 15117298
    [Abstract] [Full Text] [Related]

  • 13. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE, Otaya M, Antoniskis D, Sian S, Wang F, Mercado A, Davidson PT, Barnes PF.
    Am J Respir Crit Care Med; 1994 Dec 04; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, Padmapriyadarsini C, Ramachandran R, Chinnaiyan P, Suhadev M, Sakthivel R, Narayanan PR.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):743-51. PubMed ID: 19965813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
    Pretet S, Grosset J, Perdrizet S.
    Bull Int Union Tuberc; 1978 Dec 01; 53(4):260-1. PubMed ID: 387140
    [No Abstract] [Full Text] [Related]

  • 18. Tuberculosis control programme guidelines--treatment regimens.
    Durrheim DN, Belt EL.
    S Afr Med J; 1996 Oct 01; 86(10):1293-4. PubMed ID: 8955740
    [No Abstract] [Full Text] [Related]

  • 19. Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
    Goldberg SV, Duchin JS, Shields T, Nolan CM.
    Am J Respir Crit Care Med; 1999 Aug 01; 160(2):508-12. PubMed ID: 10430721
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].
    Chaulet P.
    Bull Int Union Tuberc; 1985 Aug 01; 60(1-2):31-3. PubMed ID: 4074970
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.